(Q45012320)

8 December 2017

title

Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis (English)

1 reference

8 December 2017

11

1 reference

8 December 2017

24

1 reference

8 December 2017

58

Ulrich Schüller

0 references

Almos Klekner

26

Almos Klekner

0 references

Noppadol Larbcharoensub

52

Noppadol Larbcharoensub

0 references

Monika Warmuth-Metz

66

Monika Warmuth-Metz

1 reference

8 December 2017

70

Nada Jabado

0 references

Claudia C Faria

Claudia C Faria

20

0 references

Juliette Hukin

Juliette Hukin

32

0 references

Lucia Roque

Lucia Roque

21

0 references

Jian-Qiang Lu

Jian-Qiang Lu

14

0 references

Gary D. Bader

Gary D Bader

65

0 references

Eric Bouffet

71

Eric Bouffet

1 reference

8 December 2017

3

Lucie Lafay-Cousin

1 reference

8 December 2017

67

Stefan Rutkowski

1 reference

8 December 2017

60

Tarik Tihan

1 reference

8 December 2017

63

James T Rutka

1 reference

8 December 2017

Rishi R Lulla

49

0 references

Adam Fleming

Adam J Fleming

48

0 references

Michael D. Taylor

Michael D Taylor

62

0 references

Suradej Hongeng

Suradej Hongeng

53

0 references

Nongnuch Sirachainan

51

Nongnuch Sirachainan

1 reference

8 December 2017

Jonathon Torchia

1

1 reference

8 December 2017

Daniel Picard

2

1 reference

8 December 2017

Cynthia E Hawkins

4

1 reference

8 December 2017

Seung-Ki Kim

5

1 reference

8 December 2017

Louis Letourneau

6

1 reference

8 December 2017

Young-Shin Ra

7

1 reference

8 December 2017

King Ching Ho

8

1 reference

8 December 2017

Tiffany Sin Yu Chan

9

1 reference

8 December 2017

Patrick Sin-Chan

10

1 reference

8 December 2017

Stephen Yip

12

1 reference

8 December 2017

Ho-Keung Ng

13

1 reference

8 December 2017

Steffen Albrecht

15

1 reference

8 December 2017

José Pimentel

16

1 reference

8 December 2017

Jennifer A Chan

17

1 reference

8 December 2017

Gino R Somers

18

1 reference

8 December 2017

Maria Zielenska

19

1 reference

8 December 2017

Berivan Baskin

22

1 reference

8 December 2017

Diane Birks

23

1 reference

8 December 2017

Douglas Strother

25

1 reference

8 December 2017

Miklos Garami

27

1 reference

8 December 2017

Peter Hauser

28

1 reference

8 December 2017

Tibor Hortobágyi

29

1 reference

8 December 2017

Laszló Bognár

30

1 reference

8 December 2017

Beverly Wilson

31

1 reference

8 December 2017

Anne-Sophie Carret

33

1 reference

8 December 2017

Timothy E Van Meter

34

1 reference

8 December 2017

Hideo Nakamura

35

1 reference

8 December 2017

Helen Toledano

36

1 reference

8 December 2017

Iris Fried

37

1 reference

8 December 2017

Daniel Fults

38

1 reference

8 December 2017

Takafumi Wataya

39

1 reference

8 December 2017

Chris Fryer

40

1 reference

8 December 2017

David D Eisenstat

41

1 reference

8 December 2017

Katrin Scheineman

42

1 reference

8 December 2017

Donna Johnston

43

1 reference

8 December 2017

Jean Michaud

44

1 reference

8 December 2017

Shayna Zelcer

45

1 reference

8 December 2017

Robert Hammond

46

1 reference

8 December 2017

David A Ramsay

47

1 reference

8 December 2017

Jason R Fangusaro

50

1 reference

8 December 2017

Muhammad Abrar Barakzai

54

1 reference

8 December 2017

Alexandre Montpetit

55

1 reference

8 December 2017

Derek Stephens

56

1 reference

8 December 2017

Richard G Grundy

57

1 reference

8 December 2017

Theodore Nicolaides

59

1 reference

8 December 2017

Joanna Phillips

61

1 reference

8 December 2017

Peter Dirks

64

1 reference

8 December 2017

Torsten Pietsch

68

1 reference

8 December 2017

Alexander R Judkins

69

1 reference

8 December 2017

Annie Huang

72

1 reference

8 December 2017

publication date

14 April 2015

1 reference

Lancet Oncology Commission

8 December 2017

published in

1 reference

8 December 2017

volume

16

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

569-582

1 reference

Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

ATP-dependent chromatin remodeling in neural development.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Statistical Significance of Clustering for High-Dimension, Low–Sample Size Data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Acheate-scute like 1 (Ascl1) is required for normal delta-like (Dll) gene expression and notch signaling during retinal development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Notch receptor-ligand binding and activation: insights from molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Lhx2 regulates the development of the forebrain hem system.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Expression of Meis2, a Knotted-related murine homeobox gene, indicates a role in the differentiation of the forebrain and the somitic mesoderm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Zic2 is required for neural crest formation and hindbrain patterning during mouse development.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970114-2

7 January 2021

10.1016/S1470-2045(15)70114-2

Identifiers

DOI

1 reference

8 December 2017

1 reference